Papulopustular Rosacea
📧 Sign up to get email alerts when something new happens for Papulopustular Rosacea.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS withdrawal · 2025-10-03Clinical Trial Update: Study to Evaluate the Safety of ATR-04 [Phase 1, Phase 2]
A Phase 1/Phase 2 safety study of ATR-04 by Azitra Inc. has been withdrawn.
-
CLINICAL_TRIALS withdrawal · 2025-01-24Clinical Trial Update: Deucravacitinib Rosacea [Phase 2]
A Phase 2 trial evaluating deucravacitinib for papulopustular rosacea has been withdrawn. The sponsor listed is Icahn School of Medicine at …